The Ty Beal Show cover image

The Hungry Brain: Why We Can't Stop Eating and What to Do About It | Stephan Guyenet, PhD

The Ty Beal Show

00:00

GLP-1 Agonists: Transforming Weight Loss

This chapter explores the role of GLP-1 agonists in treating obesity and type 2 diabetes, emphasizing their mechanisms in appetite regulation and insulin secretion. It highlights the advancements in these medications, particularly semaglutide and terzepatide, which facilitate significant weight loss while also offering potential benefits for cardiovascular and mental health. Additionally, practical aspects such as side effects and cost considerations are discussed, providing a comprehensive view of these innovative treatments.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app